Limosilactobacillus reuteri LRE02 (DSM 23878) (formerly Lactobacillus reuteri)

Gastroenterology
Anti-pathogenic activity
Supports broad anti-pathogenic activity [in vitro]
Single strain
Blend
Finished dosage form
a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
For blends containing LRE02, see the following Blends and Products pages:
- FLOR-EN® Baby
Urology
Kidney Stones
Supports healthy oxalate metabolism [in vitro]
Single strain
Blend
Finished dosage form
a) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
For information on blends containing LRE02, see the Blends and Products pages listed above.